title: Accessible xenografts of human synovium in the subcutaneous tissues of the ears of SCID mice.
abstract: This work was undertaken to examine whether human synovium could be engrafted into subcutaneous pouches in the ears of severe combined immunodeficient (SCID) mice. Synovium was transplanted into surgically constructed ear pouches. The grafts were examined by histological and immunohistochemical methods after varying periods after engraftment, or after percutaneous injection of TNF-alpha. Normal, osteo-arthritic and rheumatoid synovium was engrafted successfully in subcutaneous ear pouches. The general morphology and cellular compositions of xenografts were retained including human endothelial cells. In rheumatoid xenografts, macrophages, fibroblasts and lymphocytes persisted for at least 4 weeks. Vascular expression of intercellular adhesion molecule-1 (ICAM-1) was maintained but expression of vascular adhesion molecule-1 (VCAM-1), E-selectin and MHC class II diminished with time. Percutaneous injection of TNF-alpha induced up-regulation of VCAM-1. Human synovium can be engrafted into subcutaneous ear pouches in SCID mice. The xenografts are accessible and respond to injection of a pro-inflammatory cytokine.
authors.affiliation: Arthritis Research Laboratory, Hanson Centre for Cancer Research, Adelaide, South Australia, Australia. proudman@camtech.net.au
authors.forename: S M
authors.initials: SM
authors.lastname: Proudman
authors.forename: L G
authors.initials: LG
authors.lastname: Cleland
authors.forename: M
authors.initials: M
authors.lastname: Fusco
authors.forename: G
authors.initials: G
authors.lastname: Mayrhofer
mesh_terms: D000328:Adult; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000473:pathology; D005260:Female; D006085:Graft Survival; D006801:Humans; D016130:Immunophenotyping; D008297:Male; D051379:Mice; D016513:Mice, SCID; D008875:Middle Aged; D018919:Neovascularization, Physiologic; D010003:Osteoarthritis / Q000276:immunology / Q000473:pathology; D011994:Recombinant Proteins / Q000276:immunology / Q000494:pharmacology; D000074402:Synovectomy; D013583:Synovial Membrane / Q000276:immunology*; D014183:Transplantation, Heterologous / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000494:pharmacology
chemical_list: D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha